Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin
Horm Metab Res 11:655658, 1977 Baxter JN, Jenkens SA, Day DW, Roberts DC, Cowelt DC, Mackie CR, Shields R: Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in rat
Remedy does not publish public prices
When FDA-approved (expected 2027-2028), the commercial list price is projected at $1,000-1,500/month, though manufacturer savings programs may reduce out-of-pocket costs to $25-50/month for insured patients
Muscle & Growth Pathway Research This category focuses on how the body regulates growth-related signals